Insider Selling: SQI Diagnostics Inc. (CVE:SQD) Director Sells 189,000 Shares of Stock

SQI Diagnostics Inc. (CVE:SQD) Director Gerald R. Connor sold 189,000 shares of the stock in a transaction on Monday, December 11th. The shares were sold at an average price of C$0.16, for a total value of C$30,240.00.

SQI Diagnostics Inc. (CVE:SQD) remained flat at $C$0.19 during trading on Friday. The company’s stock had a trading volume of 14,720 shares, compared to its average volume of 65,529. The stock has a market cap of $19.74, a price-to-earnings ratio of -3.17 and a beta of 1.35. SQI Diagnostics Inc. has a fifty-two week low of C$0.10 and a fifty-two week high of C$0.24.

ILLEGAL ACTIVITY WARNING: “Insider Selling: SQI Diagnostics Inc. (CVE:SQD) Director Sells 189,000 Shares of Stock” was originally reported by Week Herald and is the property of of Week Herald. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://weekherald.com/2017/12/31/sqi-diagnostics-inc-sqd-director-gerald-r-connor-sells-189000-shares.html.

About SQI Diagnostics

SQI Diagnostics Inc (SQI) is a Canada-based diagnostics company. The Company develops multiplexed tests and automated systems for customers needing to measure a range of biomarkers in blood or other common sample types. It offers three different platforms sqidlite, sqid x and the siqdworks to run and analyze its microarray plates.

Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply